Company: MDCXW
Filing Date: 2025-07-03
Form Type: 253G2
Source: 0001062993-25-012537
Chunk: 1

Company: Medicus Pharma Ltd.
Filing Date: 2025-07-03
Form: 253G2
Chunk 1
---
 Offering Circular or this offering circular supplement is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this offering circular supplement is July 3, 2025.</div>

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________ FORM 8-K/A (Amendment No. 1) CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 29, 2025 MEDICUS PHARMA LTD.
(Exact name of registrant as specified in its charter)

| Ontario                      | 001-42408               | 98-1778211         |
| (State or other jurisdiction 
 of incorporation)            | -Commission File Number | -IRS Employer      
 Identification No. |

300 Conshohocken State Road, Suite 200
Conshohocken, Pennsylvania, United States 19428
(Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (610) 540-7515 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ( seeGeneral Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

| Title of each class                                                                     |     | Trading Symbol(s) |     | Name of each exchange on which registered |
| Common shares, no par value                                                             |     | MDCX              |     | NASDAQ Capital Market                     |
| Warrants, each exercisable for one common share at an exercise price of $4.64 per share |     | MDCXW             |     | NASDAQ Capital Market                     |

Indicate by check mark whether the registrant is an emerging growth